Stay updated on Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page
- Check5 days agoChange DetectedA new site revision entry, Revision: v3.5.4, was added to the history, superseding the previous Revision: v3.5.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s displayed ClinicalTrials.gov revision/version number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check34 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision: v3.5.0 was added to the history and Revision: v3.4.3 was removed from the history.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision history now includes Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.0%

- Check98 days agoChange DetectedAdded References and Study Status sections and updated the record to Revision v3.4.2 on 2026-02-05, while removing the old government-funding notice and Revision v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Lenvatinib in Urothelial Carcinoma Clinical Trial page.